MYDA Advisors’s Aravive, Inc. Common Stock ARAV Stock Holding History

MYDA Advisors’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,533	Closed	-$47K	–	196
2017 Q4	$47K	Buy	+3,533	New	+$45.5K	0.02%	148

Other funds holding ARAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MYDA Advisors's ARAV Position: Q1 2018 in Review

MYDA Advisors sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2018, closing a stake of 3,533 shares — an estimated $47K sold.

MYDA Advisors first reported a position in ARAV in Q4 2017 and held it in 1 quarter. The position peaked at $47K in Q4 2017. 69 funds tracked by Wall St. Rank hold ARAV as of Q1 2018.

MYDA Advisors reported no remaining Aravive, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
MYDA Advisors sold 3,533 Aravive, Inc. Common Stock shares in Q1 2018, an estimated $47K.
MYDA Advisors first reported a position in Aravive, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
MYDA Advisors's Aravive, Inc. Common Stock position peaked at $47K in Q4 2017.
69 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2018.

Based on MYDA Advisors's 13F filing for Q1 2018, filed 10 May 2018.